First AD

Second AD

Implications of ESMO Guidelines for IGHV-Mutated vs Unmutated CLL 

Video content above is prompted by the following:

How does your treatment approach differ for IGHV-mutated vs unmutated CLL?

Video Series

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Chronic Lymphocytic Leukemia

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 

ASH 2024: Global Updates in the Management of Chronic Lymphocytic Leukemia  

Peer Exchange

A panel of medical experts continues their discussion surrounding an array of treatment options for CLL.

Tailoring Treatment Approaches for Fit vs Unfit CLL Patients